|
|
|
Geron
Reports on Insulin-Producing Embryonic Stem Cells |
|
|
| May
17, 2007--Geron
Corp. reports that human
embryonic stem cells can be transformed into
insulin-producing pancreatic cells, offering the potential
to treat diabetes. Geron worked with University of Alberta
researchers, who have developed a transplant technique
called the Edmonton Protocol. Reuters
|
|
|
|
|
|
